Public annual accounts

Dr. RVA SHEORAJPANDAY financials

Name: Dr. RVA SHEORAJPANDAY financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. RVA SHEORAJPANDAY, with comparable measures and links to available source documents.

Company overview

Registry number

0807962884

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for Dr. RVA SHEORAJPANDAY

2025 versus 2024

Operating line: €479,315
EBITDA: €392,707
Total assets: €2,830,182
Equity: €1,712,059

EBITDA margin +81.9% · Equity ratio +60.5%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€479,315	€392,707	€2,830,182	€1,712,059	-
202431 Dec 2024	€477,238	€391,191	€2,830,885	€1,652,826	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€479,315

€392,707

€2,830,182

€1,712,059

202431 Dec 2024

€477,238

€391,191

€2,830,885

€1,652,826